Victory Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $452K | Sell |
|
|||||
|
2025
Q2 | $538K | Buy |
|
|||||
|
2025
Q1 | $178K | Buy |
|
|||||
|
2024
Q4 | $176K | Sell |
|
|||||
|
2024
Q3 | $189K | Sell |
|
|||||
|
2024
Q2 | $158K | Sell |
|
|||||
|
2024
Q1 | $133K | Sell |
|
|||||
|
2023
Q4 | $161K | Buy |
|
|||||
|
2023
Q3 | $144K | Buy |
|
|||||
|
2023
Q2 | $142K | Sell |
|
|||||
|
2023
Q1 | $172K | Sell |
|
|||||
|
2022
Q4 | $29.1M | Sell |
|
|||||
|
2022
Q3 | $44.4M | Sell |
|
|||||
|
2022
Q2 | $48.3M | Buy |
|
|||||
|
2022
Q1 | $57.5M | Buy |
|
|||||
|
2021
Q4 | $6.11M | Sell |
|
|||||
|
2021
Q3 | $6.67M | Sell |
|
|||||
|
2021
Q2 | $10.3M | Sell |
|
|||||
|
2021
Q1 | $6.97M | Sell |
|
|||||
|
2020
Q4 | $6.9M | Sell |
|
|||||
|
2020
Q3 | $4.11M | Buy |
|
|||||
|
2020
Q2 | $1.38M | Buy |
|
|||||
|
2020
Q1 | $100K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $50K | Buy |
|